MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Myomo Total Liabilities 2011-2026 | MYO
Annual Total Liabilities Myomo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.8 M | 4.69 M | 3.14 M | 4.77 M | 1.86 M | 1.53 M | 19.2 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.2 M | 1.53 M | 5.57 M |
Quarterly Total Liabilities Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.5 M | 21.1 M | 19.2 M | 17.5 M | 7.02 M | 6.51 M | 5.62 M | 5.59 M | 6.03 M | 4.48 M | 4.1 M | 3.8 M | 4.34 M | - | 5.11 M | 4.69 M | 4.31 M | 3.9 M | 4.86 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 4.77 M | 4.77 M | 4.77 M | 4.77 M | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 1.53 M | 1.53 M | 1.53 M | 1.53 M | 6.52 M | 6.52 M | 6.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.1 M | 1.53 M | 5.74 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M |  USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.88 | -1.02 % | $ 134 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 6.9 | -4.17 % | $ 495 M |  Israel |
 |
Alphatec Holdings
ATEC
|
126 M | $ 13.17 | -2.23 % | $ 1.88 B | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 292.08 | -0.55 % | $ 8.24 B | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 36.61 | -13.72 % | $ 5.46 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
1.34 B | $ 41.57 | -1.8 % | $ 1.28 B | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 74.23 | 1.03 % | $ 109 B | USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 112.24 | -1.19 % | $ 195 B | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
13.8 M | $ 13.0 | -2.8 % | $ 351 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.82 | -1.73 % | $ 180 M |  France |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
10.6 M | $ 23.39 | -7.4 % | $ 198 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
81.9 M | $ 14.36 | 0.81 % | $ 1.14 B | Israel |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
IRadimed Corporation
IRMD
|
11.5 M | $ 99.45 | -3.52 % | $ 1.26 B | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.54 | -0.22 % | $ 122 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.46 B | $ 84.9 | -2.62 % | $ 2.85 B | USA |
 |
Globus Medical
GMED
|
1.07 B | $ 87.0 | -1.43 % | $ 11.8 B | USA |
 |
Pulmonx Corporation
LUNG
|
77 M | $ 1.44 | -1.03 % | $ 56.3 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 10.88 | -2.68 % | $ 838 M | USA |
 |
Establishment Labs Holdings
ESTA
|
294 M | $ 72.93 | 0.29 % | $ 2.05 B |  Costa-rica |
 |
Medigus Ltd.
MDGS
|
20 M | - | 10.28 % | $ 55.5 M | Israel |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.35 | -5.59 % | $ 21.8 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.63 | 1.76 % | $ 34.3 M | USA |